Search

New findings from Greece and Japan describe advances in lung cancer. Study 1: Patients with advanced or metastatic non-small-cell lung cancer (NSCLC) treated by front-line paclitaxel and topotecan chemotherapy had [...]

Data on lung cancer are outlined in reports from the United States and Germany. Study 1: The maximum tolerated dose (MTD) of radiation therapy (RT) in patients with unresectable non-small-cell [...]

Investigators in the United States and Germany have published new cancer treatment data. Study 1: A second-line regimen of irinotecan and docetaxel was not recommended over single-agent regimens for treating [...]

Investigators in Spain, Canada and the United States have published new lung cancer data. Study 1: The response rate of advanced non-small cell lung cancer (NSCLC) was not improved with [...]

Data on lung cancer are outlined in reports from Greece, Italy and Spain. Study 1: Patients with advanced or metastatic non-small-cell lung cancer (NSCLC) treated by front-line paclitaxel and topotecan [...]

Lung cancer research advances have been reported from the United States and Austria. Study 1: Selected non-small cell lung cancer (NSCLC) patients undergoing resection after induction therapy could be treated [...]

Reports from the United States, Japan and South Korea highlight recent research in lung cancer. Study 1: Lung cancer bearing epidermal growth factor receptor variant III (EGFRvIII) mutations are sensitive [...]

New findings from Spain, Italy and France describe advances in lung cancer. Study 1: Elderly patients with early stage non-small cell lung cancer (NSCLC) could be treated by radiation therapy [...]

Lung cancer research advances have been reported from Italy and France. Study 1: Stage IIIB-IV non small cell lung cancer (NSCLC) could be treated by gemcitabine and epirubicine. According to [...]

New findings from Germany, Greece and Japan describe advances in lung cancer. Study 1: The efficacy of chemoradiation in lung cancer awaits prospective clinical evidence. "For the treatment of locoregional [...]

Reports from the United States and Japan highlight recent research in lung cancer. Study 1: Scientists believe that pemetrexed should be the standard treatment choice for unresectable malignant pleural mesothelioma [...]

Data on lung cancer are outlined in reports from Taiwan, France and Spain. Study 1: Lung cancer patients could be treated with weekly docetaxel, which produces less myelosuppression, and better [...]

Reports from South Korea, France and Italy highlight recent research in lung cancer. Study 1: Gemcitabine-cisplatin (GP) was proposed as the standard treatment for advanced non-small cell lung cancer (NSCLC) [...]

Lung cancer research advances have been reported from Germany, Greece and Japan. Study 1: The efficacy of chemoradiation in lung cancer awaits prospective clinical evidence. "For the treatment of locoregional [...]

Data on lung cancer are outlined in reports from the United States and France. Study 1: Stage I non-small cell lung cancer (NSCLC) could be treated by radiofrequency ablation (RFA) [...]

Lung cancer research advances have been reported from Italy and Netherlands. Study 1: Elderly non-small cell lung cancer (NSCLC) patients could be treated by carboplatin and paclitaxel as first line [...]

Reports from Italy and Spain highlight recent research in lung cancer. Study 1: Lung cancer survival could be extended by adding gemcitabine to paclitaxel/carboplatin (PC). According to recent research from [...]

Lung cancer data are the focus of recent research from France, Italy and the United States. Study 1: Non-small cell lung cancer (NSCLC) could be treated by carboplatin/gemcitabine, an alternative [...]

New findings from Sweden, Germany and the United States describe advances in radiotherapy. Study 1: Non-small cell lung cancer (NSCLC) could be treated by stereotactic hypofractionated radiotherapy. According to a [...]

New findings from Italy and Spain describe advances in lung cancer. Study 1: Lung cancer survival could be extended by adding gemcitabine to paclitaxel/carboplatin (PC). According to recent research from [...]

Data on lung cancer are outlined in reports from the United States, Greece and Netherlands. Study 1: First-line treatment regimens for elderly patients with non-small cell lung carcinoma (NSCLC) were [...]

Reports from Sweden, Germany and the United States highlight recent research in radiotherapy. Study 1: Non-small cell lung cancer (NSCLC) could be treated by stereotactic hypofractionated radiotherapy. According to a [...]

Investigators in Italy and the United States have published new lung cancer data. Study 1: Adjuvant chemotherapy for non-small cell lung cancer (NSCLC) was discussed. "Radical surgery remains the only [...]

Lung cancer research advances have been reported from Netherlands, United Kingdom and Australia. Study 1: The use of PET-CT for radiotherapy planning in lung cancer was reviewed. "In the last [...]

Lung cancer research advances have been reported from Italy, the United States and the United Kingdom. Study 1: Gemcitabine and cisplatin could be used to treat elderly patients with non-small [...]

Reports from Japan, the United States and the United Kingdom highlight recent research on lung cancer. Study 1: Chemoradiotherapy for lung cancer was described. According to recent research from Japan, [...]

Lung cancer data are the focus of recent research from Japan and Netherlands. Study 1: Complete resection could be used to treat non-small cell lung cancer patients. "Right upper lobectomy [...]

Lung cancer research advances have been reported from Sweden, Japan and Netherlands. Study 1: Gemcitabine was compared to gemcitabine/carboplatin in metastatic non-small-cell lung cancer (NSCLC). "This phase III study compared [...]

New findings from Taiwan, the United Kingdom and Turkey describe advances in lung cancer. Study 1: Gefitinib was shown to be an effective treatment of patients with non-small cell lung [...]

Lung cancer research advances have been reported from Italy, the United Kingdom and the United States. Study 1: Docetaxel could be used to treat advanced non-small cell lung cancer (NSCLC). [...]

New findings from Japan and Netherlands describe advances in lung cancer. Study 1: Multiplanar reformats (MPRs) from multidetector-row computed tomography (MDCT) data sets could be used to assess the extent [...]

Lung cancer research advances have been reported from the United States, Turkey and Australia. Study 1: Administration of concurrent chemoradiotherapy with gemcitabine could improve survival outcomes in locally advanced non-small [...]

Lung cancer research advances have been reported from the United Kingdom, Japan and Turkey. Study 1: Gemcitabine and carboplatin could be used to treat non-small-cell lung cancer (NSCLC). "Gemcitabine plus [...]

New findings from the United Kingdom and Japan describe advances in lung cancer. Study 1: Gefitinib plus best supportive care was used to treat patients with refractory advanced non-small-cell lung [...]

Cancer Therapy research advances have been reported from South Korea, Australia and United Kingdom. Study 1: Induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with etoposide and cisplatin [...]

New findings from the United Kingdom, Japan and South Korea describe advances in chemotherapy. Study 1: The efficacy of cisplatin and platinum(IV) complexes was unaffected by tumor microenvironmental factors. "The [...]

A long-term follow up of patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer finds a promising long-term survival regimen. According to recent research published [...]

New findings from France, Greece and the United States describe advances in lung cancer. Study 1: The outcome of 100 pneumonectomies after induction therapy was revealed. "We sought to assess [...]

Point Therapeutics, Inc. (POTP) announced that it initiated its phase III program in metastatic non-small cell lung cancer (NSCLC) to further evaluate the company's lead compound, talabostat, in patients with [...]

Lung cancer research advances have been reported from Germany and Taiwan. Study 1: Adrenalectomy was performed on adrenal metastases from non-small cell lung cancer (NSCLC). According to recent research from [...]

Cisplatin research advances have been reported from Japan and Italy. Study 1: Antipyrine test was used to predict docetaxel and cisplatin chemotherapy pharmacodynamics. Researchers in Japan reported, "To clarify the [...]

Allos Therapeutics, Inc., (ALTH) announced the publication of results from its phase 2 multi-center study of Efaproxyn (efaproxiral) in patients with unresectable non-small cell lung cancer (NSCLC) receiving sequential chemoradiotherapy [...]

Investigators in Turkey, the United States and Italy have published new lung cancer data. Study 1: An accelerated radiotherapy scheme was used to treat unresectable stage III non-small cell lung [...]

Oncology data are the focus of recent research from Japan and France. Study 1: Low VEGF levels may indicate lung cancer's response to gefitinib. "To investigate the changes in angiogenic [...]

Data on lung cancer are outlined in reports from Japan, the United States and the South Korea. Study 1: Researchers discussed the surgical treatment of lung cancer patients with chronic [...]